Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;15(5):885-887.
doi: 10.1007/s11739-020-02365-5. Epub 2020 May 18.

Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19

Affiliations
Comment

Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19

Riccardo Sarzani et al. Intern Emerg Med. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Schematic of the protective role of ACE2 and counter-regulatory renin–angiotensin–aldosterone system (RAAS) in lung injuries potentially leading to ARDS. ARB therapy, in animal models, counterbalances the down-regulation of ACE2, like the one caused by the SARS-CoV-2 infection in lung. ARB could lead to an increase in the protective components of the RAAS (by reduction of Ang II/AT1R stimulation, increase in Ang II substrate, increase in Ang II and Ang A conversion in Ang 1–7 and Alamandine, respectively) with potential prevention and/or attenuation of ARDS. ACE2: angiotensin-converting-enzyme 2; Ang: angiotensin; ARB: angiotensin II type 1 receptor blockers; AT1R: angiotensin II type 1 receptor; AT2R: angiotensin II type 2 receptor; SARS-CoV-2: severe acute respiratory syndrome coronavirus-2; MasR: Mas receptor; MrgD: Mas-related G protein-coupled receptor D; AD: aspartate decarboxylase; ARDS: acute respiratory distress syndrome

Comment on

References

    1. Spannella F, et al. Renin-angiotensin system blockers and statins are associated with lower in-hospital mortality in very elderly hypertensives. J Am Med Dir Assoc. 2018;19(4):342–347. doi: 10.1016/j.jamda.2017.09.023. - DOI - PubMed
    1. Shen L, et al. Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases. Shock. 2009;31(5):500–506. doi: 10.1097/SHK.0b013e318189017a. - DOI - PubMed
    1. Imai Y, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112–116. doi: 10.1038/nature03712. - DOI - PMC - PubMed
    1. Santos RAS, et al. The renin-angiotensin system: going beyond the classical paradigms. Am J Physiol Heart Circ Physiol. 2019;316(5):H958–H970. doi: 10.1152/ajpheart.00723.2018. - DOI - PMC - PubMed
    1. Zhang P, et al. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized With COVID-19. Circ Res. 2020 doi: 10.1161/CIRCRESAHA.120.317134. - DOI - PMC - PubMed